ノースカロライナにおける間質性肺疾患の臨床試験
ノースカロライナ内の拠点で、間質性肺疾患に関する18件の研究が参加者を募集しています。
ノースカロライナ内の都市
公式研究テキスト（英語）
FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression
- Coastal Carolina Health Care, P.A. Pulmonary and Sleep Medicine, New Bern
- Southeastern Research Center-Winston-Salem-61365, Winston-Salem
被験者募集中第3相
18歳以上 · 全性別 · 2026/10/01更新 · NCT07540988Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- USA011, Durham
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/29更新 · NCT07179380LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- CTR South Cary, Cary
- Onsite Clinical (Rowan Diagnostic), Salisbury
被験者募集中第2相
18歳〜80歳 · 全性別 · 2026/09/29更新 · NCT05798923A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
- GSK Investigational Site, Durham
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/08更新 · NCT06572384A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
- University of North Carolina at Chapel Hill, Chapel Hill
被験者募集中第2相
40歳以上 · 全性別 · 2026/09/04更新 · NCT06968845Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
- Southeastern Research Center, Winston-Salem
被験者募集中
18歳以上 · 全性別 · 2026/09/02更新 · NCT06911632A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
- Clinical Research Site, Greensboro
被験者募集中第2相
18歳〜85歳 · 全性別 · 2026/09/02更新 · NCT07333183DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- University of North Carolina at Chapel Hill, Chapel Hill
- Duke University School of Medicine, Durham
- Pulmonix, LLC, Greensboro
- 他2件
被験者募集中観察研究
18歳以上 · 全性別 · 2026/08/26更新 · NCT06388421Platform Clinical Study for Conquering Scleroderma
- Duke University Medical Center, Durham
被験者募集中第2相
18歳以上 · 全性別 · 2026/08/18更新 · NCT06195072RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
- Duke University, Durham
被験者募集中第2/3相
18歳〜75歳 · 全性別 · 2026/08/17更新 · NCT06328777Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
- UNC Chapel Hill, Chapel Hill
- Duke University, Durham
- Pulmonix LLC, Greensboro
- 他1件
被験者募集中観察研究
21歳以上 · 全性別 · 2026/08/12更新 · NCT01915511H01 in Adults With Interstitial Lung Disease (The SOLIS Study)
- NIEHS Clinical Research Unit (CRU), Research Triangle Park
被験者募集中第2相
18歳〜100歳 · 全性別 · 2026/07/28更新 · NCT06325696Abatacept for the Treatment of Common Variable Immunodeficiency With Interstitial Lung Disease
- Duke University Health System, Durham
被験者募集中第2相
4歳以上 · 全性別 · 2026/07/22更新 · NCT04925375Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
- Duke University Medical Center, Durham
- PulmonIx LLC, Greensboro
- East Carolina University, Greenville
- 他1件
被験者募集中第3相
18歳以上 · 全性別 · 2026/07/13更新 · NCT05943535Pulmonary Hypertension SOLAR
- Duke University Medical Center, Durham
被験者募集中第2相
18歳以上 · 全性別 · 2026/02/24更新 · NCT04778046129Xe MRI Cardiopulmonary
- Duke University Medical Center, Durham
被験者募集中第2相健康なボランティア歓迎
18歳以上 · 全性別 · 2026/02/04更新 · NCT06038630Hyperpolarized 129Xe MRI for Imaging Pulmonary Function
- Duke University Medical Center, Durham
被験者募集中第2相健康なボランティア歓迎
18歳以上 · 全性別 · 2026/01/16更新 · NCT01280994Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis
- Southeastern Research Center, Winston-Salem
被験者募集中第2相
40歳以上 · 全性別 · 2025/11/12更新 · NCT05975983ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。